Mayne Pharma shares surge on $407 mln takeover offer from Gedeon Richter
Mayne Pharma (ASX:MYX) accepted a A$604M ($407M) takeover offer from Gedeon Richter (BU:GDRB) at A$6.40 per share, a 99.4% premium. MYX shares surged 86.3%. The deal, pending approvals, is expected to close in March 2027. Richter aims to expand its U.S. presence in women's health.
